Explore the vast range of titles available.

Poems for young adults, 11 and older, who are going through changes and looking for answers.

In an interview, poet Sara Holbrook discusses how youth might get started in writing and performing poetry. She believes that teachers can teach kids good language lessons through poetry.

Follow the author as she guides young writers in performing poetry with style and pizzazz. More than 30 poems to practice with.

TO ONE who had taught for many years in a small New England college where there was no \"retirement system\" the subject was of small moment and seemed something vague and far away and to have little personal significance. Then came many changes in rapid succession, the war with its army training program, followed by the post-war expansion, a new administration and the sudden awareness that among other changes was the inauguration of a \"retirement system.\"

Higher maternal plasma glucose (PG) concentrations, even below gestational diabetes mellitus (GDM) thresholds, are associated with adverse offspring outcomes, with DNA methylation proposed as a mediating mechanism. Here, we examined the relationships between maternal dysglycaemia at 24 to 28 weeks' gestation and DNA methylation in neonates and whether a dietary and physical activity intervention in pregnant women with obesity modified the methylation signatures associated with maternal dysglycaemia. We investigated 557 women, recruited between 2009 and 2014 from the UK Pregnancies Better Eating and Activity Trial (UPBEAT), a randomised controlled trial (RCT), of a lifestyle intervention (low glycaemic index (GI) diet plus physical activity) in pregnant women with obesity (294 contol, 263 intervention). Between 27 and 28 weeks of pregnancy, participants had an oral glucose (75 g) tolerance test (OGTT), and GDM diagnosis was based on diagnostic criteria recommended by the International Association of Diabetes and Pregnancy Study Groups (IADPSG), with 159 women having a diagnosis of GDM. Cord blood DNA samples from the infants were interrogated for genome-wide DNA methylation levels using the Infinium Human MethylationEPIC BeadChip array. Robust regression was carried out, adjusting for maternal age, smoking, parity, ethnicity, neonate sex, and predicted cell-type composition. Maternal GDM, fasting glucose, 1-h, and 2-h glucose concentrations following an OGTT were associated with 242, 1, 592, and 17 differentially methylated cytosine-phosphate-guanine (dmCpG) sites (false discovery rate (FDR) ≤ 0.05), respectively, in the infant's cord blood DNA. The most significantly GDM-associated CpG was cg03566881 located within the leucine-rich repeat-containing G-protein coupled receptor 6 (LGR6) (FDR = 0.0002). Moreover, we show that the GDM and 1-h glucose-associated methylation signatures in the cord blood of the infant appeared to be attenuated by the dietary and physical activity intervention during pregnancy; in the intervention arm, there were no GDM and two 1-h glucose-associated dmCpGs, whereas in the standard care arm, there were 41 GDM and 160 1-h glucose-associated dmCpGs. A total of 87% of the GDM and 77% of the 1-h glucose-associated dmCpGs had smaller effect sizes in the intervention compared to the standard care arm; the adjusted r2 for the association of LGR6 cg03566881 with GDM was 0.317 (95% confidence interval (CI) 0.012, 0.022) in the standard care and 0.240 (95% CI 0.001, 0.015) in the intervention arm. Limitations included measurement of DNA methylation in cord blood, where the functional significance of such changes are unclear, and because of the strong collinearity between treatment modality and severity of hyperglycaemia, we cannot exclude that treatment-related differences are potential confounders. Maternal dysglycaemia was associated with significant changes in the epigenome of the infants. Moreover, we found that the epigenetic impact of a dysglycaemic prenatal maternal environment appeared to be modified by a lifestyle intervention in pregnancy. Further research will be needed to investigate possible medical implications of the findings. ISRCTN89971375.

Background Continuous 24‐h electrocardiographic (ECG) recording is a well‐established method for the detection of intermittent arrhythmias in veterinary medicine. The clinical utility of 24‐h ECG for the detection of intermittent arrhythmias in hospitalized goats has not been reported. Hypothesis/Objectives (1) Determine the clinical feasibility of continuous 24‐h ECG monitoring in goats; (2) Report the frequency of ventricular arrhythmias in healthy and hospitalized medically ill goats. Animals Eleven healthy goats, 20 hospitalized medically ill goats. Methods Prospective clinical study. Continuous 24‐h ECG recordings were performed. Electrocardiograms were analyzed for rhythm diagnosis. The number of ventricular premature depolarizations (VPD) was compared between groups using the Wilcoxon rank sum test. Results The ECG monitors were well‐tolerated in 30/31 goats, with no adverse effects. Twenty‐eight recordings were of sufficient quality for analysis with a median readable time of 23 h (range, 15–24 h). Eleven goats had ventricular arrhythmias (4 healthy, 7 medically ill), consisting of single VPDs only in 7 goats (3 healthy, 4 medically ill), VPDs and ventricular couplets in 4 goats (1 healthy, 3 medically ill), and ventricular rhythm consistent with accelerated idioventricular rhythm (AIVR) or ventricular tachycardia in 2 goats (2 medically ill). A significant difference in the number of VPDs in healthy goats (median, 0; range, 0–9) and medically ill goats was not identified (median, 0; range, 0–201; p = 0.66), but a larger sample size is required. Conclusion and Clinical Importance Most goats tolerated 24‐h ECG monitoring well, although a few recordings were of poor quality. Ventricular arrhythmias were seen in healthy and medically ill goats.

We describe an antiviral small molecule, LJ001, effective against numerous enveloped viruses including Influenza A, filoviruses, poxviruses, arenaviruses, bunyaviruses, paramyxoviruses, flaviviruses, and HIV-1. In sharp contrast, the compound had no effect on the infection of nonenveloped viruses. In vitro and in vivo assays showed no overt toxicity. LJ001 specifically intercalated into viral membranes, irreversibly inactivated virions while leaving functionally intact envelope proteins, and inhibited viral entry at a step after virus binding but before virus-cell fusion. LJ001 pretreatment also prevented virus-induced mortality from Ebola and Rift Valley fever viruses. Structure-activity relationship analyses of LJ001, a rhodanine derivative, implicated both the polar and nonpolar ends of LJ001 in its antiviral activity. LJ001 specifically inhibited virus-cell but not cell-cell fusion, and further studies with lipid biosynthesis inhibitors indicated that LJ001 exploits the therapeutic window that exists between static viral membranes and biogenic cellular membranes with reparative capacity. In sum, our data reveal a class of broad-spectrum antivirals effective against enveloped viruses that target the viral lipid membrane and compromises its ability to mediate virus-cell fusion.